Shenzhen, China- January 30, 2024 – MGI Tech Co., Ltd. (known as MGI), a number one supplier of cutting-edge instruments and know-how for all times science and healthcare analysis, at present introduced a strategic enlargement of its automation product strains. This enlargement covers pattern pretreatment, pattern preparation and built-in testing, leveraging its modern applied sciences and experience in genetic sequencing and multi-omics.
MGI’s automation product strains intention to handle the rising demand for high-throughput, environment friendly and dependable options in precision medication, precision agriculture, precision healthcare and associated industries.
MGI’s full automation product portfolio
Pattern Pre-treatment:
MGI’s pattern pre-treatment merchandise, extending from its profitable COVID testing portfolio, together with the Excessive-throughput Automated Pattern Switch Processing System MGISTP-7000 and the Automated Pattern Switch Processing System MGISTP-3000. These options will now cowl a broader spectrum of samples and assays, together with pattern assortment and extraction. The main target
is on enabling quick and correct DNA/RNA extraction, a pivotal step for downstream evaluation.
Pattern Preparation:
MGI’s pattern preparation merchandise provide a various vary of programs for nucleic acid library development. Highlights embrace the Excessive-throughput Automated Pattern Preparation System MGISP-960, the Automated Pattern Preparation System MGISP-100, and the upgraded
MGISP-Sensible 8 system that includes ProcessGo software program for improved integration and user-friendly options, and the revolutionary automated lab-on-a-chip system DNBeLab-D4 system. The DNBeLab-D4, leveraging superior microfluidics know-how, ensures unparalleled precision in
digital PCR purposes, setting a brand new normal for accuracy and effectivity in nucleic acid quantification. Moreover, the MGI-Glab system, a completely automated resolution for giant scale initiatives, can deal with as much as 1000’s samples per day, offering tailor-made options for medical laboratories, analysis institutes, and biotechnology firms.
Automated Pattern Preparation System MGISP-100
automated lab-on-a-chip system DNBeLab-D4 system
MGISP-Sensible 8 system
Built-in Testing:
MGI’s built-in testing system function the MGIFLP-L50 system, a modular sequencing workstation integrating the complete sequencing workflow into one machine. This totally automated resolution helps various analysis and purposes in microbiology, reproductive well being and extra.
MGIFLP-L50 system
MGI’s enlargement of automation product strains emphasizes its dedication to clever innovation in life sciences, and offering superior instruments that improve effectivity, accuracy, and analysis
turnaround instances. Its complete workflow options eradicate bottlenecks, enabling researchers to give attention to consequence evaluation quite than labour-intensive duties.
“MGI is proud to announce the enlargement of our automation product strains, offering superior options to our life science and healthcare companions. Our imaginative and prescient contains elevated automation and clever options, empowering researchers for data-driven decision-making and contributing to societal development via steady innovation.” stated Duncan Yu, President of MGI.
MGI will showcase its full portfolio of automation options for laboratories at SLAS2024 and Medlab Center East 2024. MGI welcomes all attendees to go to its subsidiary Full Genomics’ sales space #1337 at SLAS2024 in Boston, from 3-7 February and sales space #Z4.H10 at Medlab Center East 2024 in Dubai from 5-8 February.
